Tag: Mylan Comments on Generic Advair Diskus® Abbreviated New Drug Application
Mylan Comments on Generic Advair Diskus® Abbreviated New Drug Application
HERTFORDSHIRE, England and PITTSBURGH, March 29, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today commented on the status of its abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) for...